Pharmafile Logo
Pharmafocus logo
Advanced Search

blood

Showing 15 posts of 17 posts found.

Xarelto image

Bayer promotes Xarelto benefits

June 15, 2015
Sales and Marketing Bayer, Eliquis, Xarelto, blood, law suits, rivaroxaban

Bayer HealthCare is releasing new evidence to suggest that the risk of taking its best-selling blood thinner Xarelto is outweighed …

News
Novartis image

Novartis drug to treat iron overload gets US nod

March 31, 2015
Sales and Marketing FDA, Novartis, blood, deferasirox, exjade, iron, jadenu

Novartis’ iron overload drug Jadenu has been given the green light by US regulators to treat patients with a serious …

News
Daiichi image

Daiichi-Sankyo blood drug gets FDA nod

January 12, 2015
Sales and Marketing BMS, Daiichi Sankyo, Daiichi-Sankyo, FDA, Pfizer, Pradaxa, atrial fibrillation, blood, savaysa

The US Food and Drug Administration has shown Daiichi-Sankyo’s anti-clotting drug Savaysa the green light to reduce the risk of …

News
Soliris image

NHS to get world’s most expensive drug

November 27, 2014
Sales and Marketing Alexion, NICE, aHUS, beauchamp, blood, eculizumab, soliris

UK health watchdog NICE has recommended Alexion’s Soliris for patients with the rare disease atypical haemolytic uremic syndrome (aHUS).  Soliris …

News
eliquis image

Pfizer/BMS blood thinner gains new licence

August 22, 2014
Sales and Marketing BMS, DVT, Eliquis, Pfizer, Pradaxa, Xarelto, blood, warfarin

Pfizer and Bristol-Myers Squibb have been handed a much-needed lift after its new blood thinner Eliquis gained a licence extension …

News
Brilinta image

Reprieve for AstraZeneca as US drops drug investigation

August 19, 2014
Sales and Marketing AstraZeneca, Brilinta, US, blood, justice, plato

The US Justice Department has pulled a controversial investigation into AstraZeneca’s pivotal clinical trial after finding no wrongdoing. The inquiry …

News
Gilead image

FDA approves Gilead’s blood cancer drug

July 24, 2014
Research and Development, Sales and Marketing Cancer, FDA, Gilead, blood, follicular lymphoma and small lymphocytic lymphoma, lymphocytic leukaemia, sovaldi, zydelig

The Food and Drug Administration has approved Gilead Sciences new treatment Zydelig (idelalisib) to treat three types of blood cancer.  …

News
Pradaxa image

BMJ investigation raises new concerns over Pradaxa

July 24, 2014
Medical Communications, Research and Development, Sales and Marketing BMJ, Boehringer, Channel 4, Pradaxa, blood, warfarin

An investigation by The BMJ has raised fresh concerns about Boehringer’s top-selling blood thinner Pradaxa (dabigatran) and the regulatory decisions …

News

Boehringer blood cancer drug scores in Phase II

July 9, 2014
Research and Development, Sales and Marketing Boehringer, blood, giotrif, leukaemia, volasertib

Less than a year after securing its first cancer drug on the market with Giotrif, Boehringer has taken another decisive …

News
Lilly image

Lilly’s Efient tipped for expanded NICE approval

June 20, 2014
Sales and Marketing Effient, Efient, FDA, NHS, blood, lilly, longston, thinner

 Eli Lilly’s anti-platelet drug Efient has been given the nod by UK healthcare watchdog NICE for more widespread use, pending …

News
Pradaxa image

Pradaxa gets DVT indication

June 6, 2014
Sales and Marketing Boehringer, DVT, Pradaxa, blood, dabigatran etexilate, thinner

Pradaxa has been given approval in Europe to treat deep vein thrombosis (DVT) and pulmonary embolism (PE) just a week …

News
boehringer image

Boehringer settles US lawsuits

May 29, 2014
Medical Communications, Sales and Marketing Boehringer, Pradaxa, US, blood, lawsuits, warfarin

Boehringer Ingelheim has sought to bring to an end around 4,000 legal cases which have been brought against the company …

News
Soliris image

Alexion ‘concerned’ over NICE draft

March 4, 2014
Sales and Marketing NICE, aHUS, alexia, blood, eculizumab, soliris

Alexion Pharmaceuticals UK has expressed ‘concern’ that NICE has not yet allowed its rare disease treatment Soliris to be formally …

News
GSK sign

GSK submits new Promacta licence

March 3, 2014
Sales and Marketing GSK, NICE, Promacta, Revolade, blood, eltrombopag

GlaxoSmithKline is seeking a new licence for its blood disorder drug Promacta in patients with severe aplastic anaemia. Specifically, the …

News
Xarelto, bayer, ACS, janssen, fda, asa, blood

Bayer ‘disappointed’ with FDA

February 18, 2014
Sales and Marketing ACS, Bayer, Xarelto, blood, rivaroxaban

Bayer HealthCare has expressed its dismay after the Food and Drug Administration once again rejected further indications for the company’s …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026